"The bottom line is that Spectrum remains a fairly risky stock at this stage in its evolution due to the lack of a franchise-level product in its current portfolio. While that could change within the next year or so as its pipeline matures, my take is that this biotech is perhaps best viewed as a strong watch list candidate heading into apaziquone's target PDUFA date of Dec. 11, 2016". Motley Fool Post. I Am So Excited!
I Am Not Whining I Am Offering A Reality Check For Potential New Investors You Intend To Extract Wealth From. I Am Not Alone In My Opinion Though!
How Many Times Has This Happened? It Seems Like Every Time It Gets Over Or Around $7.35. It Stalls Out As The Sell It Short. Now Someone Has Spent Major Dollars To Place A Bet On $3.00. What Do They Know Joe? Please Do A Couple Of Lines Joe, So You Can Tell Us What Is Planned For Real Shareholders.
But I Am Not Working For 10 Cents A Post And A Line Of White Powder Laid Out On A Mirror Four Times A Day. Do You Have Allergies, Your Sniffling?
Now You Know Why They Are Pumping This Stock Price. Unfortunately The New Shares And A Bunch Of The Existing Ones Are Most Likely "Sold Short" As The Reward For Pumping On A Bad Quarterly Report. This May Be The Basis For The Universal Assumption That Raj Is Always Working With The Shorts. If True, This Would Qualify As A Symbiotic Relationship Where One Can Not Survive Without The Other. Just My Thoughts, You Do The Math.
3,025,000 Divided By 41 Days Equals 73,789,48 Shares A Day. Or $553,353.60 A Day.
That Would Be A 4.3843% Increase In Shares That We Know About.Here Are Some Things We Do Know.
More Shares With Even More Dilution After Quarter Ended, Lost Money (-14 ), 18,Million Less In Assets, 6 Drugs On The Market And Less Total Dollars Of Sales, Less Total Stockholders Equity, Greater Accumulated Deficit,Marqibo Sales Off 50% Fusilev Sales Off 25%, Zevalin Sales Off 34%, STOCK BASED COMPENSATION UP 29.4%, Restricted Stock Awards Up By 1,000,000 Shares, AND MOST IMPORTANTLY "CASI will be responsible for the development and commercialization of these three drugs, including the submission of import drug registration applications to regulatory authorities and conducting any confirmatory clinical studies in greater China. We will provide CASI with future commercial supply of the CASI Out-Licensed Products under typical market terms". THE LARGEST MARKET IN THE WORLD LEFT TO A COMPANY THAT HAS NEVER DEVELOPED OR MARKETED ANYTHING IN 22+ YEARS.!
When You Hear The Word Exciting In A Raj Presentation You Know He Is Lying!
It Is Always About The Future And Never The Failed Past. The Only Answer To Raj's Failings And Need Of Cash Is New Shareholders AND DILUTION.
If He Said That I Think He Is Lying Once Again!
The Massive Short Play Is What YOU Are Doing On This Board.
The Launch Of Evomela Would Have Been The Focus Of The Conference Call. Raj Would have Told The World About The Launch And First Patients Treated. He Would Have Told Shareholders That It Was Available In X Number Of Centers NOW And Given Us An Idea How Many More Centers They Propose To Market It In This Year And Given Us A Time Line And This Years Anticipated Treatments. He Stuttered And Stammered Because He Did Not Want To Lie To Shareholders While The Heat Is On SPPI.
Second Quarter Loss Will Be So Much Greater Than The First Quarter In My Opinion. Thankfully We Are Selling Some Other Companies Drugs.
But Now There is Another Short Play Because Of Poor Sales Performance Of The Existing Drug Line!
Yes I Am A "Fool" For Believing Anything That Raj Says When The Word EXCITING Is Used! He Was So Excited When He Partnered With CASI For The Largest Drug Market In The World. He Took A 1.5 Million Dollar Note From CASI And Bought Stock That Has Fallen In Price.(-$1,149,000.00 ) The Contract Seems To Not Have A Performance Clause That Stipulates That They Start Working On The Approval Of All Three Immediately! They Waited 14 Months To Start The Preliminary Application For ONE Drug Only. The Other Two Drugs Have Seen NO Advancement Whatsoever!
Wow I Feel So Slighted! You Sat Next To Me In The Third World English Class Sponsored By UNICEF.